The Food and Drug Administration approved the VisuMax Femtosecond Laser for use in a surgical procedure to reduce or eliminate myopia — nearsightedness — in patients.
The VisuMax Femtosecond Laser uses a very fast, short-pulsed beam to cut a disc-shaped piece of tissue from the cornea, which when removed, changes the shape of the eye to correct myopia.
In a recent clinical study of 328 patients treated with the device, all but one participant had uncorrected visual acuity of 20/40 or better and 88 percent had acuity of 20/20 or better.
Dublin, Calif.-based Carl Zeiss Meditec manufactures the device.
More articles on supply chain:
Regional Health wins supply chain performance award
Indiana Blood Center pleads for O-negative donations
Study: Supply chain execs more likely to exhibit psychopathic traits